| Original language | English (US) |
|---|---|
| Pages (from-to) | 2465-2469 |
| Number of pages | 5 |
| Journal | Blood Advances |
| Volume | 3 |
| Issue number | 16 |
| DOIs | |
| State | Published - Aug 27 2019 |
Bibliographical note
Funding Information:The authors thank the BMT CTN for providing the samples. Research reported in this publication was supported by the National Institutes of Health, National Cancer Institute (grant P30CA077598) utilizing the Biostatistics and Bioinformatics Core and the Biospecimen Repository in the Translational Therapy Laboratory Shared Resource of the Masonic Cancer Center, University of Minnesota and by the National Center for Advancing Translational Sciences of the National Institutes of Health (award number UL1-TR002494). National Institutes of Health, National Cancer Institute grants P01 CA111412 and P01 CA65493 provided partial support. BMT CTN is supported by the National Institutes of Health, National Heart, Lung, and Blood Institute and National Cancer Institute (grant U10HL069294). The Department of the Navy, Office of Navy Research, and the National Marrow Donor Program also provided support for the BMT CTN-0201 study. Enrollment support was provided by DKMS (Deutsche KnochenMarkSpenderdatei) Germany.
Funding Information:
Research reported in this publication was supported by the National Institutes of Health, National Cancer Institute (grant P30CA077598) utilizing the Biostatistics and Bioinformatics Core and the Biospecimen Repository in the Translational Therapy Laboratory Shared Resource of the Masonic Cancer Center, University of Minnesota and by the National Center for Advancing Translational Sciences of the National Institutes of Health (award number UL1-TR002494). National Institutes of Health, National Cancer Institute grants P01 CA111412 and P01 CA65493 provided partial support. BMT CTN is supported by the National Institutes of Health, National Heart, Lung, and Blood Institute and National Cancer Institute (grant U10HL069294). The Department of the Navy, Office of Navy Research, and the National Marrow Donor Program also provided support for the BMT CTN-0201 study. Enrollment support was provided by DKMS (Deutsche KnochenMarkSpenderdatei) Germany.
